Merck & Company Inc (MRK)vsTandem Diabetes Care Inc (TNDM)
MRK
Merck & Company Inc
$148.35
-0.80%
HEALTHCARE · Cap: $335.46B
TNDM
Tandem Diabetes Care Inc
$21.43
+0.14%
HEALTHCARE · Cap: $1.49B
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 6292% more annual revenue ($66.57B vs $1.04B). MRK leads profitability with a 4.8% profit margin vs -6.1%. MRK earns a higher WallStSmart Score of 34/100 (F).
MRK
Avoid34
out of 100
Grade: F
TNDM
Avoid28
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-84.6%
Fair Value
$82.62
Current Price
$148.35
$65.73 premium
Intrinsic value data unavailable for TNDM.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Generating 4.5B in free cash flow
No standout strengths identified
Areas to Watch
Trading at 8.7x book value
ROE of 7.6% — below average capital efficiency
4.8% margin — thin
Elevated debt levels
Trading at 11.4x book value
Smaller company, higher risk/reward
Weak financial health signals
ROE of -71.4% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Free Cash Flow.
Bull Case : TNDM
TNDM has a balanced fundamental profile.
Bear Case : MRK
The primary concerns for MRK are Price/Book, Return on Equity, Profit Margin. A P/E of 108.8x leaves little room for execution misses. Thin 4.8% margins leave little buffer for downturns.
Bear Case : TNDM
The primary concerns for TNDM are Price/Book, Market Cap, Piotroski F-Score. Debt-to-equity of 5.67 is elevated, increasing financial risk.
Key Dynamics to Monitor
MRK profiles as a value stock while TNDM is a turnaround play — different risk/reward profiles.
TNDM carries more volatility with a beta of 1.54 — expect wider price swings.
TNDM is growing revenue faster at 5.8% — sustainability is the question.
MRK generates stronger free cash flow (4.5B), providing more financial flexibility.
Bottom Line
MRK scores higher overall (34/100 vs 28/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Tandem Diabetes Care Inc
HEALTHCARE · MEDICAL DEVICES · USA
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United States. The company is headquartered in San Diego, California.
Visit Website →Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?